This is the authors' abstract. We don't add key points for this paper.
[18F]T807 is currently being tested in humans as a tau positron emission tomography (PET) tracer. Described as selectively binding to tau aggregates as opposed to Ab or a-synuclein aggregates, T807 was also reported to be selective against 72 additional targets including MAO-A and MAO-B . [3H]T807 and T807 were characterized in binding assays using recombinant proteins and native tissues. We found that [3H]T807 bound with nanomolar affinity on recombinant K18/K19 tau fibrils, in human and rat brain homogenates and on crude tau paired helical filaments (PHF) isolated from human brains. However, this binding was clearly heterogeneous with high and low affinity binding sites. T807 selectivity profiling at 10 μM revealed significant inhibition (>85%) on μ-opioid and 5-HT2B receptors and on MAO-A. T807 affinity for μ-opioid and 5-HT2B receptors was in the micromolar range and it inhibited MAO-A enzyme activity with an IC50 of 1 μM. Surprisingly, we found that clorgyline, a selective MAO-A ligand, was able to fully displace [3H]T807 from its high affinity binding sites in human and rat brain homogenates. The affinity of clorgyline for these binding sites was ∼3 nM in line with its reported MAO-A affinity. As expected, clorgyline displayed low affinity for [3H]T807 binding site on PHF and K18/K19 fibrils. To further probe the potential binding of [3H]T807 to MAO-A, we measured [3H]T807 binding to recombinant human MAO-A and found a reversible and high affinity binding with a KDof 1.5 nM, that was selectively displaced by clorgyline and other MAO-A reference ligands. Conversely, T807 also competed with nanomolar affinity against [3H]Ro41-1049 labeled rat native MAO-A. Taken together, these data unambiguously demonstrate that T807 labels with similar high affinity tau aggregates and MAO-A. As MAO-A is widely expressed in most human brain regions, these findings raise caution to the interpretation of the T807 PET clinical data. References: 1. Xia et al. Alzheimer's & Dementia (2013) 9(6):666-76. 2. Fowler et al. Mol Imaging Biol (2005) 7:377-87 3. 3. Saura et al. J Neurosci. (1992) 5:1977-99.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Vermeiren et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: